Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes

Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes

Abstract Background Epidemiological studies of chemotherapy‐induced peripheral neuropathy (CIPN) have predominantly focused on non‐Hispanic White patients, despite the observation that African Americans are more likely to experience CIPN. To address this health disparities gap, we sought to identify...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthew R. Trendowski, Christine M. Lusk, Julie J. Ruterbusch, Randell Seaton, Michael S. Simon, Mark K. Greenwald, Felicity W. K. Harper, Jennifer L. Beebe‐Dimmer, Ann G. Schwartz
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
African Americans
chemotherapy‐induced peripheral neuropathy
health disparities
quality of life
risk
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/f7126e1a2b374146bee112253b537bb1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f7126e1a2b374146bee112253b537bb1

Ejemplares similares